Neil K. Warma

Neil K. Warma has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Acer Therapeutics Inc. and ProMIS Neurosciences Inc. Between 11 August 2008 and 3 February 2026, the trades on record add up to 13 filings.

Every open-market trade on record is a purchase: 3 purchases worth €19k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 7 share grants and 1 option exercise.

A typical purchase (the median) is worth €6,575.

The latest filing, published on 5 February 2026, reports a share grant of €64k in ProMIS Neurosciences Inc. The last insider purchase was made public on 17 September 2014, 4,420 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.